news
Dr. Betouke Ongwe successfully defends her PhD exploring metabolic profiling following immunological perturbations
On 4 February 2025, Dr. Madeleine Eunice Betouke Ongwe successfully defended her PhD thesis at the University of Leiden entitled “Metabolic profiling following immunological perturbations: comparison across individuals from different geographical areas”. Dr. Betouke Ongwe’s research examined metabolic responses to immunological challenges in populations with distinct geographical, microbial and parasitic exposures. Her research aimed to identify metabolic differences that influence immune responses to vaccines and infection in Sub-Saharan African and European individuals.
EMBO Global Investigator Network Webinar
On Tuesday 18 March 2025, the European Molecular Biology Organization (EMBO) will be hosting a webinar about their Global Investigator Network programme. Registration for the webinar is now open and speakers include HypoVAX Global researcher Dr Gyaviira Nkurunungi of Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine.
Full registration details for the webinar can be found here, including insights into the speakers and topics covered.
Professor Alison Elliott honoured with an OBE award for services to Medicine and Global Health
In recognition of her dedication and services to medicine and global health, Professor Alison Elliott was honoured with an OBE (Officer of the Order of the British Empire) award in King Charles III’s 2025 New Year Honours. Prof. Elliott is Professor of Tropical Medicine at London School of Hygiene & Tropical Medicine (LSHTM) and theme leader for vaccines research at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit. She has been an active part of HypoVax Global from our inception as a partner and advisor.
HypoVaxed Newsletter #3
In the second quarter of 2024, HypoVax Global Knowledge Hub has been busy establishing new connections, exploring potential collaborative projects and welcoming a new PhD researcher working on an exciting project. Find out about our key highlights, upcoming events, researcher spotlight, field story and more.
Findings from the POPVAC studies highlight determinants of vaccine response in Uganda
Exciting new findings related to vaccine hyporesponsiveness have just been published by our HypoVax Global partners based at the MRC/UVRI LSHTM Uganda Research Unit in Entebbe, Uganda.
In the November 2024 issue of The Lancet Global Health journal, four insightful articles from the groundbreaking POPVAC (Population Differences in Vaccine response) clinical trials are out now. Funded by the UKRI / MRC, the POPVAC trials ran between 2018 and 2022 and explored how environmental factors as well as chronic infections shape immune responses across adolescent schoolchildren living in distinct urban-rural areas in Uganda.
Hypovax Newsletter #2
In the second quarter of 2024, HypoVax Global Knowledge Hub has been busy establishing new connections, exploring potential collaborative projects and welcoming a new PhD researcher working on an exciting project. Find out about our key highlights, upcoming events, researcher spotlight, field story and more.
Reverse meets Captan
REVERSE meets CapTan: Fostering the spirit of collaboration within HypoVax Global.
HypoVax Global researchers conduct multiple projects in parallel. There is often overlap in research activities that enable researchers to travel to the field together and thus demonstrating how strong collaboration among members of the hub can be key in achieving goals. Dr. Mariateresa Coppola who leads the REVERSE-Tonsil project had the opportunity to travel to Tanzania with scientists working on the CapTan study. Here we highlight Dr. Coppola’s experiences in the field.
KNAW funding for online mentorship programme
We are delighted to announce that HypoVax Global has received a financial contribution from the Royal Netherlands Academy of Arts and Sciences (KNAW)’s Van Walree Fund to initiate an online mentorship programme that aims to support women researchers in the field of vaccine research.
HypoVaxed Newsletter #1
In 2023, the HypoVax Global Knowledge Hub was launched within the Leiden University Center for Infectious Diseases (LUCID). Find out about our key highlights, upcoming events, researcher spotlight, field story and more.
Lorentz workshop “Connecting people to reverse vaccine hyporesponsiveness”
Between 12th and 16 February 2024, we hosted the first HypoVax Global workshop entitled “Connecting people to reverse vaccine hyporesponsiveness”. The workshop took place at the Lorentz Center located in Leiden, the Netherlands. The Lorentz Center is well known for hosting international scientific meetings that are innovative, engaging, interactive and of high scientific quality.